Biphenyl

Biphenyl

SCHEMBL5324255

C=CCCl.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
L3MBTL1 Q9Y468 2/20 0.44
CYP1A2 P05177 1/20 0.43
TSHR P16473 2/20 0.39
TAAR1 Q96RJ0 2/20 0.39
MMP9 P14780 1/20 0.38
HTT P42858 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 2/20 0.38
MAPK1 P28482 1/20 0.38
NPC1 O15118 1/20 0.38
MITF O75030 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NOTUM Q6P988 1/20 0.38
MMP3 P08254 1/20 0.38
BCL2L1 Q07817 1/20 0.38
HPGD P15428 2/20 0.37
IDH1 O75874 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL5697712 0.82 TDP1 (0.33) ALDH1A1TSHRTDP1
Biphenyl SCHEMBL27472529 0.79 ALDH1A1 (0.60) ALDH1A1L3MBTL1CYP1A2TSHRTAAR1
Phenol SCHEMBL6846541 0.79 CA12 (0.55) ALDH1A1CYP1A2TSHRNPC1TDP1
Styrene SCHEMBL11405863 0.79 ALDH1A1 (0.70) ALDH1A1L3MBTL1TSHRMAPK1NPC1
(Chloromethyl)Benzene SCHEMBL28189836 0.79 MAOB (0.40) ALDH1A1L3MBTL1TSHRTAAR1HSD17B10
Biphenyl SCHEMBL151980 0.78 ALDH1A1 (0.69) ALDH1A1CYP1A2TSHRTAAR1HTT
Benzene SCHEMBL728398 0.78 TDP1 (0.31) TDP1
Biphenyl SCHEMBL3258858 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1TSHRTAAR1MMP9
Biphenyl SCHEMBL16146354 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP1A2TSHRTAAR1
Biphenyl SCHEMBL7803891 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP1A2TSHRTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778652-A2 COMPOSITIONS AND METHODS COMPRISING PROTEINASE ACTIVATED RECEPTOR ANTAGONISTS EntreMed, Inc. (US) 2007-05-02 EP disclosed
US-20060063930-A1 Compositions and methods comprising proteinase activated receptor antagonists ENTREMED, INC. 2006-03-23 US disclosed
WO-2006023844-A2 COMPOSITIONS AND METHODS COMPRISING PROTEINASE ACTIVATED RECEPTOR ANTAGONISTS ENTREMED, INC. (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063930-A1 Compositions and methods comprising proteinase activated receptor antagonists F2RL1, PLAUR, F2R ALDH1A1 4556/4885L3MBTL1 4373/4885CYP1A2 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.